Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments
FDA Law Blog
OCTOBER 14, 2024
These procedures are offered to treat a variety of conditions, including Alzheimer’s, arthritis, asthma, cancer, etc., Court Opinion One of Defendant’s primary arguments was that its SVF treatments constituted the practice of medicine, not the manufacture and administration of a “drug” and were, therefore, not subject to FDA regulation.
59 
Let's personalize your content